OVOCA’S BIZARRE SWITCH OFFERS HUGE UPSIDE POTENTIAL

Kirill Golovanov

IT IS clearly very odd that a company that has long traded in the natural resources sector has, overnight, turned itself into a pharmaceutical operation. This exact transformation took place on Friday July 27 at an EGM, without even a whimper from the Irish Stock Exchange head honchos. Instead, essentially, of exploring for gold in… Read more »